DXR
Daxor Corporation
NASDAQ: DXR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$10.80
+1.41% today
Updated 2026-04-30
Market cap
$59.73M
P/E ratio
6.25
P/S ratio
2,238.07x
EPS (TTM)
$1.64
Dividend yield
—
52W range
$7 – $15
Volume
0.0M
Daxor Corporation (DXR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
-74.4%
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-06-30 | $0.00 | $-0.07 | — | $18348.00 | -74.4% |
| 2025-03-31 | $0.00 | $0.00 | — | — | — |
| 2024-12-31 | $0.00 | $0.43 | — | $695307.00 | +743.3% |
| 2024-09-30 | $0.00 | $0.00 | — | — | — |
| 2024-06-30 | $0.00 | $0.00 | — | $71756.00 | -11.4% |
| 2024-03-31 | $0.00 | $0.00 | — | $35878.00 | -11.4% |
| 2023-12-31 | $0.00 | $0.00 | — | $82448.00 | -14.5% |
| 2023-09-30 | $0.00 | $0.00 | — | $41224.00 | -14.5% |
| 2023-06-30 | $0.00 | $0.00 | — | $80974.00 | — |
| 2023-03-31 | $0.00 | $0.00 | — | $40487.00 | — |
| 2022-12-31 | $0.00 | $1.54 | — | $96398.00 | — |
| 2022-09-30 | $0.00 | $0.00 | — | $48199.00 | — |
Frequently asked questions
Has Daxor Corporation beaten earnings estimates?
Daxor Corporation has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports.
What is Daxor Corporation's revenue growth rate?
Daxor Corporation reported year-over-year revenue growth of -74.4% in its most recent quarter.